Accredo offers a wide range of medications to treat various complex and chronic conditions. Visit Conditions to learn more about treatment, medications, and support for your condition.
| Medication | Condition(s) | Generic/Biosimilar | Manufacturer |
|---|---|---|---|
| Tafinlar® (dabrafenib) | Novartis Pharmaceuticals Corp. | ||
| Tagrisso® (osimertinib) |
Lung cancer
|
AstraZeneca | |
| Takhzyro™ (lanadelumab-flyo) | Takeda Pharmaceuticals | ||
| Taltz® (Ixekizumab) | Eli Lilly & Co. | ||
| Talzenna® (talazoparib) |
Breast cancer
|
Pfizer, Inc. | |
| Tarceva® (erlotinib) | Generic(s) Available | Genentech, Inc. and OSI Pharmaceuticals, Inc. | |
| Targretin® (bexarotene) |
Lymphoma
|
Generic(s) Available | Eisai, Inc. |
| Tascenso ODT® (fingolimod) | Generic(s) Available | Cycle Vita | |
| Tasigna® (nilotinib) |
Leukemia
|
Novartis Pharmaceuticals Corp. | |
| Tecentriq® (atezolizumab) | Genentech USA, Inc. |